COVID-19 Vaccine

India might have 100 million doses of AstraZeneca PIc’s COVID-19 shot ready by December revealed Adar Poonawala of The Serum Institute of India Ltd.

The Centre has asked states to set up panels to co-ordinate and oversee smooth COVID-19 vaccination drive in the country.

The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the DCGI told Russian news agency Sputnik.

Health Minister Harsh Vardhan on Tuesday said that India is likely to have a vaccine against the coronavirus by early next year from more than one source.

Russia's COVID-19 vaccine has side effects as 1 in 7 Volunteers have complained of weakness and muscle pain after receiving it. But they fade away after 24 hours.

The Drugs Controller General of India (DCGI) gave permission to the Pune Serum Institute of India (SII) to resume its trials of the Oxford Covid-19 vaccine.

Union Minister of Health and Family Welfare Harsh Vardhan on September 13, 2020, claimed that India shall have a vaccine ready by March 2021.

Serum Institute halts coronavirus vaccine trials in India after notice from drug regulators on why the trials are on when AstraZeneca stopped process after volunteer fell ill.

The director of the Centers for Disease Control and Prevention told governors of states to prepare for the "large-scale" distribution of a coronavirus vaccine by November.

The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin today.

The first batch of Coronavirus vaccine made by Russia's Gamaleya Institute is ready and will roll out from August-end this year.

Russia's health ministry has given regulatory approval for the world's first coronavirus vaccine, developed by Moscow's Gamaleya Institute.